EIKN
Eikon Therapeutics, Inc. Common Stock
NASDAQ: EIKN · HEALTHCARE · BIOTECHNOLOGY
$9.62
+5.54% today
Updated 2026-04-30
Market cap
$522.71M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.18
Dividend yield
—
52W range
$9 – $17
Volume
0.4M
Eikon Therapeutics, Inc. Common Stock (EIKN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-125.00%
ROA
-36.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2023 | $0.00 | $-242.00M | — | — | — |
| 2024 | $0.00 | $-243.81M | — | — | — |
| 2025 | $0.00 | $-324.25M | — | — | — |